Molecular imaging in cardiovascular disease: targets and opportunities (Q37557366)

21 August 2017

1 reference

title

Molecular imaging in cardiovascular disease: targets and opportunities (English)

1 reference

21 August 2017

main subject

cardiovascular disease

1 reference

Stanley Y Shaw

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

21 July 2009

1 reference

Nature Reviews Cardiology

21 August 2017

published in

1 reference

21 August 2017

volume

6

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

569-579

1 reference

Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Atherothrombosis and high-risk plaque: part I: evolving concepts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Targeted imaging of myocardial damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Matrix metalloproteinases A review of their structure and role in acute coronary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Extracellular proteases in atherosclerosis and restenosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

In vivo imaging of proteolytic activity in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

In vivo imaging of tumors with protease-activated near-infrared fluorescent probes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Myeloperoxidase and plaque vulnerability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

DTPA-bisamide-based MR sensor agents for peroxidase imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Novel Factor XIII Probes for Blood Coagulation Imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

In vivo detection and imaging of phosphatidylserine expression during programmed cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Annexin A5: an imaging biomarker of cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Visualisation of cell death in vivo in patients with acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Annexin-V imaging for noninvasive detection of cardiac allograft rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Imaging myocardial metabolism and ischemic memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Fatty acid metabolism and myocardial perfusion imaging for the evaluation of global left ventricular dysfunction following acute myocardial infarction: comparisons with echocardiography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Recombinant HDL-Like Nanoparticles: A Specific Contrast Agent for MRI of Atherosclerotic Plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Deve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study w

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

The significance of cardiac sympathetic nervous system abnormality in the long-term prognosis of patients with a history of ventricular tachyarrhythmia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Identifying the proteins to which small-molecule probes and drugs bind in cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Cell-specific targeting of nanoparticles by multivalent attachment of small molecules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Unbiased discovery of in vivo imaging probes through in vitro profiling of nanoparticle libraries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Vascular biomarkers and surrogates in cardiovascular disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

The Role of Molecular Imaging in Drug Discovery and Development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, dou

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Overview of early response assessment in lymphoma with FDG-PET.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Perturbational profiling of nanomaterial biologic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

Safe handling of nanotechnology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

A 18F-radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrix-metalloproteinase activity in vivo

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19621013

12 December 2020

inferred from PubMed ID database lookup

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

2 references

PubMed

https://pubmed.ncbi.nlm.nih.gov/19621013

12 December 2020

inferred from PubMed ID database lookup

https://api.crossref.org/works/10.1038/NRCARDIO.2009.119

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NRCARDIO.2009.119

1 reference

release_z4kpxjorizajhai4pbh2njlflm

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z4kpxjorizajhai4pbh2njlflm

24 November 2022

mapped directly with Wikidata item

1 reference